Lixte Biotechnology Valuation
| LIXT Stock | USD 3.05 0.07 2.24% |
At this time, the firm appears to be overvalued. Lixte Biotechnology secures a last-minute Real Value of $2.79 per share. The latest price of the firm is $3.05. Our model forecasts the value of Lixte Biotechnology from analyzing the firm fundamentals such as Current Valuation of 24.71 M, return on equity of -1.3, and Shares Owned By Insiders of 0.93 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Lixte Biotechnology's valuation include:
Overvalued
Today
Please note that Lixte Biotechnology's price fluctuation is very risky at this time. Calculation of the real value of Lixte Biotechnology is based on 3 months time horizon. Increasing Lixte Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Lixte Biotechnology's intrinsic value may or may not be the same as its current market price of 3.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.05 | Real 2.79 | Hype 3.07 |
The intrinsic value of Lixte Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lixte Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lixte Biotechnology Holdings helps investors to forecast how Lixte stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lixte Biotechnology more accurately as focusing exclusively on Lixte Biotechnology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Lixte Biotechnology's intrinsic value based on its ongoing forecasts of Lixte Biotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Lixte Biotechnology's closest peers.
Lixte Biotechnology Cash |
|
About Lixte Biotechnology Valuation
The stock valuation mechanism determines Lixte Biotechnology's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lixte Biotechnology based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lixte Biotechnology. We calculate exposure to Lixte Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lixte Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (12.83) | (13.48) | |
| Operating Profit Margin | (11.91) | (12.50) | |
| Net Loss | (12.83) | (13.48) |
Lixte Biotechnology Current Valuation Indicators
Lixte Biotechnology's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Lixte Biotechnology's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Lixte Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Lixte Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Lixte Biotechnology's worth.Additional Tools for Lixte Stock Analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.